What is Health Sciences Acquisitions 2 Financial Strength?
Health Sciences Acquisitions 2 has the Financial Strength Rank of 9. It shows strong financial strength and is unlikely to fall into distressed situations.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its
Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3.
Altman Z-Score.
Health Sciences Acquisitions 2 has no long-term debt (1).
As of today, Health Sciences Acquisitions 2's Altman Z-Score is 0.00.
(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Competitive Comparison of Health Sciences Acquisitions 2's Financial Strength
For the Shell Companies subindustry, Health Sciences Acquisitions 2's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Sciences Acquisitions 2's Financial Strength Distribution in the Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Health Sciences Acquisitions 2's Financial Strength distribution charts can be found below:
* The bar in red indicates where Health Sciences Acquisitions 2's Financial Strength falls into.
Health Sciences Acquisitions 2 Financial Strength Calculation
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Health Sciences Acquisitions 2's Interest Expense for the
months ended in Dec. 2022 was $0.00 Mil. Its Operating Income for the
months ended in Dec. 2022 was $-0.88 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $0.00 Mil.
Health Sciences Acquisitions 2's Interest Coverage for the quarter that ended in Dec. 2022 is
| Health Sciences Acquisitions 2 had no long-term debt (1). |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
Health Sciences Acquisitions 2's Debt to Revenue Ratio for the quarter that ended in Dec. 2022 is
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Health Sciences Acquisitions 2 has a Z-score of 0.00, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Sciences Acquisitions 2 (Health Sciences Acquisitions 2) Business Description
Traded in Other Exchanges
N/A
Address
40, 10th Avenue, Floor 7, New York, NY, USA, 10014
Health Sciences Acquisitions Corp 2 is a blank check company.
Executives
| Joshua Aiello |
officer: See Remarks |
150 UNION SQUARE DRIVE, NEW HOPE PA 18938 |
| Eric S Fain |
director |
ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN MN |
| Yuval Mika |
officer: See Remarks |
150 UNION SQUARE DRIVE, NEW HOPE PA 18938 |
| Jason Aryeh |
director |
11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037 |
| David P Hochman |
director, officer: See Remarks |
15 WESTON HILL RD., RIVERSIDE CT 06878 |
| Geoffrey Wade Smith |
director |
6740 SHADY OAK ROAD, EDEN PRAIRIE MN 55344 |
| Pamela Ann Connealy |
director |
320 W 37TH STREET, 3RD FLOOR, NEW YORK NY 10016 |
| Rose Eric A Md |
director |
161 FORT WASHINGTON AVENUE, 7TH FLOOR, NEW YORK NY 10032 |
| Plc Medtronic |
10 percent owner |
20 ON HATCH, LOWER HATCH STREET, DUBLIN L2 2 |
| Michael Kaswan |
officer: Chief Financial Officer |
KBL HEALTHCARE ACQUISITION CORP II, 645 MADISON AVENUE, NEW YORK NY 10022 |
| Darren Sherman |
director, officer: See Remarks |
C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301 |
| Roderick Wong |
director, 10 percent owner, officer: Chief Executive Officer |
C/O RTW INVESTMENTS, LP, 40 10TH AVENUE, 7TH FLOOR, NEW YORK NY 10014 |
| Rtw Investments, Lp |
10 percent owner |
40 10TH AVENUE, 7TH FLOOR, NEW YORK NY 10014 |
| Hsac 2 Holdings, Llc |
10 percent owner |
412 WEST 15TH STREET, FLOOR 9, NEW YORK NY 10011 |
| Stephanie A Sirota |
officer: VP-Corp Strategy & Corp Comms. |
412 WEST 15TH STREET, FLOOR 9, NEW YORK NY 10011 |
Health Sciences Acquisitions 2 (Health Sciences Acquisitions 2) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HSAQ has been successfully added to your